Crystal Structure
Crystallisation Method: EM
Corresponding Chain: A/B
Sequence Length: 50-369
Detail: Struture Info
General Information of DT | |||||
---|---|---|---|---|---|
DT ID | DTD0035 | ||||
Gene Name | SLC30A8 | ||||
Protein Name | Zinc transporter 8 | ||||
Gene ID | |||||
UniProt ID | |||||
TCDB ID | |||||
3D Structure |
Crystal Structure Crystallisation Method: EM Corresponding Chain: A/B Sequence Length: 50-369 Detail: Struture Info |
||||
Synonyms | SLC30A8; Solute carrier family 30 member 8; ZNT8; ZnT-8 | ||||
DT Family | Cation Diffusion Facilitator (CDF) Family ; | ||||
Tissue Specificity | In the endocrine pancreas, expressed ininsulin-producing beta cells. Expressed at relatively high levelsin subcutaneous fat tissue from lean persons; much lower levels invisceral fat, whether from lean or obese individuals, and insubcutaneous fat tissue from obese individuals. Expressed inperipheral blood mononuclear cells, including T-cells and B-cells,with great variation among individuals ranging from negative tostrongly positive. | ||||
Function | This transporter may be a major component for providing zinc to insulin maturation and/or storage processes in insulin-secreting pancreatic beta-cells. Facilitates the accumulation of zinc from the cytoplasm into intracellular vesicles, being a zinc-efflux transporter. | ||||
Endogenous Substrate(s) | Zn2+ | ||||
Variability Data of This Drug Transporter (DT) | |||||
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
(α) Microbiota Influence of This DT |
|||||
(β) Post-translational Modification of This DT |
|||||
(γ) Transcriptional Regulation of This DT |
|||||
(δ) Epigenetic Regulation of This DT |
|||||
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
(α) Mutation-induced Structural Variation |
|||||
(β) Inter-species Structural Differences |
|||||
General Variability Data of This DT (VARIDT 1.0) |
|||||
(α) Genetic Polymorphisms of This DT |
|||||
(β) Disease-specific Protein Abundances of This DT |
|||||
(γ) Species- and Tissue-specific DT Abundances |
|||||
Molecular Transporting Profile of This DT | |||||
Full List of Drug(s) Transported by This DT |
|||||
Withdrawn, Discontinued or Preclinical Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
Zinc salts
|
Preclinical | Drug Info | Arthritis | FA5Z | [1] |
References | |||||
1 | Zinc transporter 8 (ZnT8) and cell function. Trends Endocrinol Metab. 2014 Aug;25(8):415-24. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.